Edition:
United States

Insider Trading: AbbVie Inc (ABBV.K)

ABBV.K on New York Consolidated

66.10USD
27 Mar 2017
Change (% chg)

-- (--)
Prev Close
$66.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,056,127
52-wk High
$68.12
52-wk Low
$55.06

CHASE WILLIAM J

Institutional Holders

% Shares Owned: 69.39%
# of Holders: 2,093
Total Shares Held: 1,105,836,201
3 Mo. Net Change: -21,690,820
# New Positions: 121
# Closed Positions: 103
# Increased Positions: 837
# Reduced Positions: 842
# Net Buyers: -5

Officers & Directors

Name Age Since Current Position

Richard Gonzalez

63 2013 Chairman of the Board, Chief Executive Officer

William Chase

49 2013 Executive Vice President, Chief Financial Officer

Michael Severino

51 2014 Executive Vice President - Research & Development, Chief Scientific Officer

Laura Schumacher

53 2013 Executive Vice President, External Affairs, General Counsel and Corporate Secretary

Carlos Alban

54 2013 Executive Vice President - Commercial Operations

Henry Gosebruch

44 2015 Executive Vice President, Chief Strategy Officer

Timothy Richmond

50 2013 Senior Vice President - Human Resources

Azita Saleki-Gerhardt

53 2013 Senior Vice President - Operations

Robert Michael

46 2017 Vice President, Controller

Robert Alpern

65 2013 Independent Director

Roxanne Austin

55 2013 Independent Director

William Burnside

64 2013 Independent Director

Edward Liddy

70 2013 Independent Director

Edward Rapp

58 2013 Independent Director

Glenn Tilton

67 2013 Lead Independent Director

Frederick Waddell

62 2013 Independent Director